Regent Pacific Group Limited (HKG:0575)
0.9200
0.00 (0.00%)
Jul 30, 2026, 1:43 PM HKT
Regent Pacific Group Market Cap
Regent Pacific Group has a market cap or net worth of 268.47 million as of July 31, 2026. Its market cap has decreased by -3.16% in one year.
Market Cap
268.47M
Enterprise Value
297.92M
Revenue
2.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.92
ChartMarket Cap Chart
Since March 10, 2016, Regent Pacific Group's market cap has decreased from 13.03B to 268.47M, a decrease of -97.94%. That is a compound annual growth rate of -31.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 268.47M | -14.02% |
| Dec 31, 2025 | 312.24M | 274.48% |
| Dec 31, 2024 | 83.38M | -41.12% |
| Dec 29, 2023 | 141.60M | -25.33% |
| Dec 30, 2022 | 189.63M | -48.68% |
| Dec 31, 2021 | 369.51M | -17.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pak Fah Yeow International | 732.35M |
| Lee's Pharmaceutical Holdings | 618.28M |
| Zhongzhi Pharmaceutical Holdings | 561.34M |
| China NT Pharma Group Company | 355.87M |
| Wai Yuen Tong Medicine Holdings | 334.31M |
| Tianda Pharmaceuticals | 223.60M |
| Extrawell Pharmaceutical Holdings | 217.50M |
| Shenzhen Neptunus Interlong Bio-technique Company | 182.90M |